Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase II clinical trial to assess the efficacy of dostarlimab as neoadjuvant therapy in patients with MMRd/MSI-H stage II-III endometrial ca… Recruiting

2024-512021-81-00 MMRd/MSI-H stage II-III endometrial cancer 4 2025-12-01
DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for … Recruiting

2025-521644-37-00 locally advanced or metastatic penile squamous cell car 4 2025-11-28
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Recruiting

2024-519727-18-00 Metastatic Solid Tumor Advanced Solid Tumor Non-small C 1 2025-11-25
A clinical study of MK-1084 in people with advanced solid tumors (MK 1084-014) Recruiting

2025-521737-91-00 Neoplasm malignant with KRAS G12C mutation 4 2025-11-25
A study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo®, in combination with mFOLFOX6 and bevacizumab versus… Recruiting

2024-519590-19-00 PD-L1 positive advanced colorectal cancer 4 2025-11-25
Subcutaneous Trastuzumab Deruxtecan Phase 1 Trial. Recruiting

2024-516625-31-00 Advanced Solid Tumor 3 2025-11-25
Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with… Recruiting

2024-519048-33-00 resected pancreatic adenocarcinoma 10 2025-11-25
A study to test whether treatment with BI 770371 in combination with pembrolizumab with or without cetuximab helps people with head and neck… Recruiting

2024-517091-38-00 Head and neck squamous cell carcinoma 3 2025-11-25
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-11-24
Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) Recruiting

2024-519261-21-00 Desmoplastic small round cell tumor 4 2025-11-21
A Phase 1/2 Study of BMS-986482 Alone or Combination Therapy in Participants with Advanced Solid Tumors Recruiting

2024-516602-28-00 Advanced Solid Tumors 7 2025-11-21
A clinical study to evaluate the safety, efficacy, and impact on quality of life of capivasertib alongside routine endocrine treatment in pa… Recruiting

2024-511392-15-00 HR+/HER2- advanced breast cancer 5 2025-11-20
adIVO Recruiting

2024-520219-42-00 ivosidenib maintenance after SOC adjuvant chemotherapy 10 2025-11-18
A Study of BMS-986504 in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line M… Recruiting

2025-521511-40-00 metastatic non-small cell lung cancer 10 2025-11-18
IMAGINE 1 Recruiting

2025-522290-11-00 Cholangiocarcinoma, pancreatic cancer, colo-rectal canc 3 2025-11-18
TARLATEM : Combination of TARLAtamab and TEMozolomide in patients with central nervous system tumors. A multicenter, open-label Phase I/II t… Recruiting

2023-510568-11-00 High grade brain tumors 9 2025-11-18
A randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best in… Recruiting

2024-517018-14-00 Advanced non-small cell lung cancer 4 2025-11-17
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Recruiting

2025-520555-89-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2025-11-14
Trial of THEO-260 in Ovarian Cancer Patients (OCTOPOD) Recruiting

2024-511236-27-00 High grade serous or endometroid ovarian cancer 7 2025-11-12
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Recruiting

2024-517281-42-00 Advanced solid tumors 7 2025-11-12
Prostate Androgen Response Investigation using a Stratification BIOmarker - PARIS-BIO Recruiting

2025-520639-17-00 High-risk localized or locally advanced prostate adenoc 4 2025-11-12
A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting

2024-517553-26-00 Advanced ALK-positive non-small cell lung cancer (NSCLC 5 2025-11-12
Study of Izalontamab Brengitecan (BMS-986507) versus Treatment of Physician’s Choice in Patients with Previously Untreated, Locally Advanced… Recruiting

2024-519871-24-00 Breast cancer 10 2025-11-11
Digitoxin Pancreatic cancer trial-1 Recruiting

2024-512128-12-01 Pancreatic cancer 4 2025-11-11